Impact of indoleamine 2,3-dioxygenase on the antioxidant system in the placentas of severely pre-eclamptic patients

References

• Burton, G.J., Hempstock, J. and Jauniaux, E. (2003) Oxygen, early embryonic metabolism and free radical-mediated embryopathies. Reprod Biomed Online 6:84–96.
   PubMedGoogle Scholar
• Chappell, L.C., Seed, P.T., Briley, A.L., Kelly, F.J., Lee, R., Hunt, B.J, (1999) Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 354:810–816.
   PubMed Web of Science ®Google Scholar
• Cross, J.C. (2003) The genetics of pre-eclampsia: a feto-placental or maternal problem? Clin Genet 64:96–103.
   PubMed Web of Science ®Google Scholar
• Hall, D.R., Odendaal, H.J., Steyn, D.W. and Grove, D. (2000) Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 107:1252–1257.
   PubMed Web of Science ®Google Scholar
• Hung, T.H., Lo, L.M., Chiu, T.H., Li, M.J., Yeh, Y.L., Chen, S.F. and Hsieh, T.T. (2010) A longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation. Reprod Sci 17:401–409.
   PubMed Web of Science ®Google Scholar
• Jauniaux, E., Poston, L. and Burton, G.J. (2006) Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Hum Reprod Update 12:747–755.
   PubMed Web of Science ®Google Scholar
• Jones, M.L., Mark, P.J., Lewis, J.L., Mori, T.A., Keelan, J.A. and Waddell, B.J. (2010) Antioxidant defenses in the rat placenta in late gestation: increased labyrinthine expression of superoxide dismutases, glutathione peroxidase 3, and uncoupling protein 2. Biol Reprod 83:254–260.
   PubMedGoogle Scholar
• Mellor, A.L., Sivakumar, J., Chandler, P., Smith, K., Molina, H., Mao, D. and Munn, D.H. (2001) Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2:64–68.
   PubMed Web of Science ®Google Scholar
• Munn, D.H., Zhou, M., Attwood, J.T., Bondarev, I., Conway, S.J., Marshall, B., (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191–1193.
   PubMed Web of Science ®Google Scholar
• Myatt, L. (2010) Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 31:66–69.
   PubMed Web of Science ®Google Scholar
• Nishizawa, H., Kato, T., Ota, S., Nishiyama, S., Pryor-Koishi, K., Suzuki, M., (2010) Genetic variation in the indoleamine 2,3-dioxygenase gene in pre-eclampsia. Am J Reprod Immunol 64:68–76.
   PubMedGoogle Scholar
• Nishizawa, H., Pryor-Koishi, K., Suzuki, M., Kato, T., Sekiya, T., Tada, S., (2009) Analysis of nitric oxide metabolism as a placental or maternal factor underlying the etiology of pre-eclampsia. Gynecol Obstet Invest 68:239–247.
   PubMed Web of Science ®Google Scholar
• Nishizawa, H., Hasegawa, K., Suzuki, M., Achiwa, Y., Kato, T., Saito, K., (2008) Mouse model for allogeneic immune reaction against fetus recapitulates human pre-eclampsia. J Obstet Gynaecol Res 2008;34:1–6.
   PubMedGoogle Scholar
• Nishizawa, H., Hasegawa, K., Suzuki, M., Kamoshida, S., Kato, T., Saito, K., (2007) The etiological role of allogeneic fetal rejection in pre-eclampsia. Am J Reprod Immunol 58:11–20.
   PubMed Web of Science ®Google Scholar
• Page, N.M. (2002) The endocrinology of pre-eclampsia. Clin Endocrinol 57:413–423.
   PubMed Web of Science ®Google Scholar
• Perkins, A.V. (2006) Endogenous anti-oxidants in pregnancy and preeclampsia.'Aust N Z J Obstet Gynaecol 46:77–83.
   PubMed Web of Science ®Google Scholar
• Peter Stein, T., Scholl, T.O., Schluter, M.D., Leskiw, M.J., Chen, X., Spur, B.W. and Rodriguez, A. (2008) Oxidative stress early in pregnancy and pregnancy outcome. Free Radic Res 42:841–848.
   PubMed Web of Science ®Google Scholar
• Poston, L., Briley, A.L., Seed, P.T., Kelly, F.J. and Shennan, A.H. (2006) Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 367:1145–1154.
   PubMed Web of Science ®Google Scholar
• Roberts, J.M. and Cooper, D.W. (2001) Pathogenesis and genetics of pre-eclampsia. Lancet 357:53–56.
   PubMed Web of Science ®Google Scholar
• Roberts, J.M. and Hubel, C.A. (1999) Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet 354:788–789.
   PubMed Web of Science ®Google Scholar
• Sibai, B., Dekker, G. and Kupferminc, M. (2005) Pre-eclampsia. Lancet 365:785–799.
   PubMed Web of Science ®Google Scholar
• Takagi, Y., Nikaido, T., Toki, T., Kita, N., Kanai, M., Ashida, T., (2004) Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 444:49–55.
   PubMed Web of Science ®Google Scholar
• Takikawa, O., Kuroiwa, T., Yamazaki, F. and Kido, R. (1988) Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem 263:2041–2048.
   PubMed Web of Science ®Google Scholar
• Thomas, S.R. and Stocker, R. (1999) Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 4:199–220.
   PubMed Web of Science ®Google Scholar
• Woodage, T., Venter, J.C. and Broder, S. (2002) Application of the human genome to obstetrics and gynecology. Clin Obstet Gynecol 45:711–732.
   PubMedGoogle Scholar